We are delighted to announce that we have been successful in achieving the target for our crowdfunding project: ‘COVID-19: a first step towards developing a new drug to reduce severity of symptoms’. Thank you all for your support,
We are aware that most of us our experiencing hardship during this pandemic and we appreciate that over 200 people made a pledge towards the project. We take this as a message for us to do our utmost to forge ahead with the research. COVID-19 continues to be rampant throughout the world and we endeavour to continue the research so that the findings can contribute towards tackling the pandemic.
With regards to the extra funding, beyond the target figure, it will also go towards facilitating the project. In the meantime, we will be getting in touch with you regarding the rewards in due course.
Once again, thank you very much for your support.
Message from Professor Tatsuro Irimura
I would like to thank you from the bottom of my heart for all your support. In recent times, we have heard a lot about the UK variant of the coronavirus. In order to deal with such a variant, we need to first understand that RNA genome, which have mutated, is simply a blueprint for the novel coronavirus. The main issue to overcome with regards to such a mutation is find out how the spikes, which are sugar proteins, on the surface of the virus have mutated.
By collaborating with Glycotechnica, with its unrivalled technology for the analysis of sugar chains, we will do our best to elucidate the mechanisms of novel coronavirus infection and its malignant transformation, and to develop new diagnostic and therapeutic methods.
Tatsuro Irimura, Juntendo University
Message from Professor Norio Yamamoto
I would like to thank you from the bottom of my heart for supporting our project. With your backing, we will push forward with the research. COVID-19 continues to be rampant globally with the new variants dominating the news. Along with Glycotechnica Ltd., we endeavour to understand the mechanism behind increase in infection efficiency and severe cases through research, placing particular focus on sugar chains and lectins.
Norio Yamamoto, Tokai University